Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: Contract/Agreement

DarwinAI Now a Model Partner at Modzy


Modzy, the leading enterprise AI platform, today announced that DarwinAI is now a model partner at the Modzy AI Model Marketplace. DarwinAI is expected to deploy numerous models using its GenSynth platform, including COVID-Net, an open source deep neural network for detecting COVID-19 infections from chest X-rays. DarwinAI has been featured in the MIT Technology Review, AI in Healthcare, and VentureBeat for their innovations in combating COVID-19 using AI.

"We're really excited for this partnership with DarwinAI," said Norm Litterini, Head of Partnerships at Modzy. "The quality of their work is reflected in their solid reputation and industry acknowledgment. DarwinAI's models will enable customers to quickly operationalize AI into strategic initiatives while building out our marketplace offering, particularly for biomedical applications, where there is critical need."

Sheldon Fernandez, CEO of DarwinAI, echoed similar sentiments. "We're thrilled to be a model partner at the Modzy Marketplace. Our patented platform around Explainable AI (XAI) helps enterprises build AI they can trust in a robust and rapid manner. The acclaim we've received around COVID-Net is a testament to our technology's promise and Modzy's impressive ecosystem will be an important vehicle in helping us bring it to the enterprise."

Modzy is the enterprise AI platform to easily secure, govern, and deploy AI models. Since its launch Modzy has continually added new models to its marketplace and now offers more than 100 world-class pre-trained commercial AI models by Modzy and leading AI partners which span industry use cases and AI techniques. Biomedical organizations that run Modzy will be able to quickly adopt and economically deploy DarwinAI models.

Keep informed of Modzy developments here:
www.twitter.com/getmodzy
www.linkedin.com/company/getmodzy

About Modzy

Modzy is the leading enterprise platform to secure, govern, and deploy Artificial Intelligence (AI) models. Modzy helps government and private-sector customers meet the challenge of operationalizing AI by enabling rapid deployment, management and governance of trusted AI. Modzy's platform leverages embedded security, patented adversarial defense, explainability of model predictions, and governance features to help customers easily manage and quickly benefit from their AI investments at enterprise scale. Modzy offers choice with ready-to-deploy pre-trained and trainable AI models from leading companies and open source communities. Modzy accelerates the deployment of trustworthy AI while increasing transparency, lowering the barriers to adopting and scaling AI. To learn more visit www.Modzy.com.

About DarwinAI

DarwinAI, the explainable AI company, enables enterprises to build AI they can trust. Founded by renowned academics at the University of Waterloo, the company's patented explainability technology accelerates advanced deep learning design. DarwinAI was named a cool vendor by Gartner in 2019 and was selected by CB Insights for AI 100, an annual list of the 100 most promising private AI companies in the world. To learn more about DarwinAI, visit their website at www.darwinai.com or follow them @darwinAI on Twitter.


These press releases may also interest you

at 04:04
NaturVet, the 30-year pioneer and present-day innovator of the pet health and wellness industry, announces the latest innovation in the pet supplement realm: Breed Specific Soft Chews®. This new comprehensive line is made up of five products that...

at 04:01
Bizrahmed, a leading cosmetic center in Dubai, is delighted to announce the joining of internationally acclaimed British plastic surgeon, Mr. Norman Waterhouse. This strategic collaboration is set to be significant, as it boots the range of cosmetic...

at 04:00
Slone Partners, a nationwide executive search firm for life sciences, healthcare, and nonprofit and social impact organizations, has announced the placement of Chris A. Raanes as Chief Executive Officer (CEO) at Magnetic Insight, the global leader in...

at 03:05
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clinical trial with MH002 in the orphan disease...

at 03:00
Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it has extended the menu of DxI 9000 Immunoassay...

at 03:00
Viewpoint, the esteemed educational program hosted by distinguished actor Dennis Quaid, is pleased to announce a collaborative effort with Medical Aid International for an upcoming episode dedicated to transforming healthcare in Low and Middle Income...



News published on and distributed by: